Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/51341 |
Resumo: | Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil. |
id |
CRUZ_a9f879266744084affed1b0aabb6357b |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/51341 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Kurizky, PatriciaNóbrega, Otávio T.Soares, Alexandre Anderson De Sousa MunhozAires, Rodrigo BarbosaAlbuquerque, Cleandro Pires deNicola, André MoraesAlbuquerque, PatríciaCarvalho, Andréa Teixeira deNaves, Luciana AnsaneliFontes, WagnerLuz, Isabelle SouzaFelicori, LizaGomides, Ana Paulo MonteiroSilva, Dayde Lane MendonçaEspindola, Laila SalmenMartins Filho, Olindo AssisLima, Sheila Maria Barbosa deMota, Licia Maria HenriqueGomes, Ciro Martins2022-02-21T17:09:19Z2022-02-21T17:09:19Z2021KURIZKY, Patricia et al. Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study. JMIR Research Protocols, v. 10, n. 3, p. 1-13, e24211, 2021.1929-0748https://www.arca.fiocruz.br/handle/icict/5134110.2196/24211engJMIR PublicationsMolecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Studyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlePrograma de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil.Faculdade de Ceilândia. University of Brasília. Brasília, DF, Brazil.Fundação Oswaldo Cruz. Instituto Rene Rachou. Belo Horizonte, MG, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil.Instituto de Ciências Biológicas. University of Brasília. Brasília, DF, Brazil.Instituto de Ciências Biológicas. University of Brasília. Brasília, DF, Brazil.Instituto de Ciências Biológicas. Federal University of Minas Gerais. Belo Horizonte, MG, Brazil.Centro Universitário de Brasília. Brasília, DF, Brazil.Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil / Faculdade de Ciências da Saúde. University of Brasília. Brasília, DF, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Faculdade de Ciências da Saúde. University of Brasília. Brasília, DF, Brazil.Fundação Oswaldo Cruz. Instituto Rene Rachou. Belo Horizonte, MG, Brazil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos. Rio de Janeiro, RJ, BrazilPrograma de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil.Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil.Background: Since the beginning of the COVID-19 pandemic, the world's attention has been focused on better understanding the relation between the human host and the SARS-CoV-2 virus, as its action has led to hundreds of thousands of deaths. Objective: In this context, we decided to study certain consequences of the abundant cytokine release over the innate and adaptive immune systems, inflammation, and hemostasis, comparing mild and severe forms of COVID-19. Methods: To accomplish these aims, we will analyze demographic characteristics, biochemical tests, immune biomarkers, leukocyte phenotyping, immunoglobulin profile, hormonal release (cortisol and prolactin), gene expression, thromboelastometry, neutralizing antibodies, metabolic profile, and neutrophil function (reactive oxygen species production, neutrophil extracellular trap production, phagocytosis, migration, gene expression, and proteomics). A total of 200 reverse transcription polymerase chain reaction-confirmed patients will be enrolled and divided into two groups: mild/moderate or severe/critical forms of COVID-19. Blood samples will be collected at different times: at inclusion and after 9 and 18 days, with an additional 3-day sample for severe patients. We believe that this information will provide more knowledge for future studies that will provide more robust and useful clinical information that may allow for better decisions at the front lines of health care. Results: The recruitment began in June 2020 and is still in progress. It is expected to continue until February 2021. Data analysis is scheduled to start after all data have been collected. The coagulation study branch is complete and is already in the analysis phase. Conclusions: This study is original in terms of the different parameters analyzed in the same sample of patients with COVID-19. The project, which is currently in the data collection phase, was approved by the Brazilian Committee of Ethics in Human Research (CAAE 30846920.7.0000.0008).COVID-19TARGETBiomarkerCohortCytokine profileDesignGeneticsImmune systemImmunologyMetabolomicsNeutralizing antibodiesNeutrophil functionPrognosisProteomicsThromboelastometryVirusinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83082https://www.arca.fiocruz.br/bitstream/icict/51341/1/license.txt9193a7c197bc67acd023525e72a03240MD51ORIGINALMolecular and Cellular Biomarkers of COVID-19 Prognosis.pdfMolecular and Cellular Biomarkers of COVID-19 Prognosis.pdfapplication/pdf611387https://www.arca.fiocruz.br/bitstream/icict/51341/2/Molecular%20and%20Cellular%20Biomarkers%20of%20COVID-19%20Prognosis.pdf3c8af0f926c8888e791a0b9bc5063bbbMD52icict/513412022-03-09 22:32:30.632oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-03-10T01:32:30Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study |
title |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study |
spellingShingle |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study Kurizky, Patricia COVID-19 TARGET Biomarker Cohort Cytokine profile Design Genetics Immune system Immunology Metabolomics Neutralizing antibodies Neutrophil function Prognosis Proteomics Thromboelastometry Virus |
title_short |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study |
title_full |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study |
title_fullStr |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study |
title_full_unstemmed |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study |
title_sort |
Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study |
author |
Kurizky, Patricia |
author_facet |
Kurizky, Patricia Nóbrega, Otávio T. Soares, Alexandre Anderson De Sousa Munhoz Aires, Rodrigo Barbosa Albuquerque, Cleandro Pires de Nicola, André Moraes Albuquerque, Patrícia Carvalho, Andréa Teixeira de Naves, Luciana Ansaneli Fontes, Wagner Luz, Isabelle Souza Felicori, Liza Gomides, Ana Paulo Monteiro Silva, Dayde Lane Mendonça Espindola, Laila Salmen Martins Filho, Olindo Assis Lima, Sheila Maria Barbosa de Mota, Licia Maria Henrique Gomes, Ciro Martins |
author_role |
author |
author2 |
Nóbrega, Otávio T. Soares, Alexandre Anderson De Sousa Munhoz Aires, Rodrigo Barbosa Albuquerque, Cleandro Pires de Nicola, André Moraes Albuquerque, Patrícia Carvalho, Andréa Teixeira de Naves, Luciana Ansaneli Fontes, Wagner Luz, Isabelle Souza Felicori, Liza Gomides, Ana Paulo Monteiro Silva, Dayde Lane Mendonça Espindola, Laila Salmen Martins Filho, Olindo Assis Lima, Sheila Maria Barbosa de Mota, Licia Maria Henrique Gomes, Ciro Martins |
author2_role |
author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Kurizky, Patricia Nóbrega, Otávio T. Soares, Alexandre Anderson De Sousa Munhoz Aires, Rodrigo Barbosa Albuquerque, Cleandro Pires de Nicola, André Moraes Albuquerque, Patrícia Carvalho, Andréa Teixeira de Naves, Luciana Ansaneli Fontes, Wagner Luz, Isabelle Souza Felicori, Liza Gomides, Ana Paulo Monteiro Silva, Dayde Lane Mendonça Espindola, Laila Salmen Martins Filho, Olindo Assis Lima, Sheila Maria Barbosa de Mota, Licia Maria Henrique Gomes, Ciro Martins |
dc.subject.en.pt_BR.fl_str_mv |
COVID-19 TARGET Biomarker Cohort Cytokine profile Design Genetics Immune system Immunology Metabolomics Neutralizing antibodies Neutrophil function Prognosis Proteomics Thromboelastometry Virus |
topic |
COVID-19 TARGET Biomarker Cohort Cytokine profile Design Genetics Immune system Immunology Metabolomics Neutralizing antibodies Neutrophil function Prognosis Proteomics Thromboelastometry Virus |
description |
Programa de Pós-graduação em Ciências Médicas. Faculdade de Medicina. University of Brasília. Brasília, DF, Brazil / Hospital Universitário de Brasília. University of Brasília. Brasília, DF, Brazil. |
publishDate |
2021 |
dc.date.issued.fl_str_mv |
2021 |
dc.date.accessioned.fl_str_mv |
2022-02-21T17:09:19Z |
dc.date.available.fl_str_mv |
2022-02-21T17:09:19Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
KURIZKY, Patricia et al. Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study. JMIR Research Protocols, v. 10, n. 3, p. 1-13, e24211, 2021. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/51341 |
dc.identifier.issn.pt_BR.fl_str_mv |
1929-0748 |
dc.identifier.doi.none.fl_str_mv |
10.2196/24211 |
identifier_str_mv |
KURIZKY, Patricia et al. Molecular and Cellular Biomarkers of COVID-19 Prognosis: Protocol for the Prospective Cohort TARGET Study. JMIR Research Protocols, v. 10, n. 3, p. 1-13, e24211, 2021. 1929-0748 10.2196/24211 |
url |
https://www.arca.fiocruz.br/handle/icict/51341 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
JMIR Publications |
publisher.none.fl_str_mv |
JMIR Publications |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/51341/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/51341/2/Molecular%20and%20Cellular%20Biomarkers%20of%20COVID-19%20Prognosis.pdf |
bitstream.checksum.fl_str_mv |
9193a7c197bc67acd023525e72a03240 3c8af0f926c8888e791a0b9bc5063bbb |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798324984447238144 |